InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Drutz David, Director. Officer active across 1 companies, notably Altimmune, Inc.. In total, 8 reports have been recorded. Total volume traded: €13k. The latest transaction was filed on 15 June 2022 — Acquisition. Regulator: SEC (Form 4). All data is free.
Declarations8 total
€7,6511,000 shares@ €7.6510.0014% mcap55.2% of flow
Common Stock, par value $0.0001
SEC:0001104659-22-072059:0·
Ideal exit: 12 Mar 2023 (T+270)
€5,0301,200 shares@ €4.19130.0009% mcap36.3% of flow
Common Stock, par value $0.0001
SEC:0001104659-22-064786:0·
Ideal exit: 18 Feb 2023 (T+270)
€14870 shares@ €2.11940.0000% mcap1.1% of flow
Common Stock, par value $0.0001
SEC:0001104659-22-007911:0·
€14870 shares@ €2.119425.1% of flow
Common Stock, par value $0.0001
SEC:0001104659-22-007911·
€296139 shares@ €2.126650.0% of flow
Common Stock, par value $0.0001
SEC:0001104659-21-150119·
€296139 shares@ €2.12660.0001% mcap2.1% of flow
Common Stock, par value $0.0001
SEC:0001104659-21-150119:0·
€14870 shares@ €2.111125.0% of flow
Common Stock, par value $0.0001
SEC:0001104659-21-142052·
€14870 shares@ €2.11110.0000% mcap1.1% of flow
Common Stock, par value $0.0001
SEC:0001104659-21-142052:0·
8 of 8 declarations
About Drutz David
David Drutz is a Board Member at Altimmune, Inc. He participates in overseeing the company's activities and making strategic decisions. His experience in the biopharmaceutical field allows him to provide valuable insights to the leadership.
